The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
To expedite development, the FDA has created a special emergency program called the Coronavirus Treatment Acceleration Program.
Cohort study data from 2018 to 2019 suggest poor compliance with the US Food and Drug Administration reporting requirements for clinical trial sponsors.
Many providers who are required to take recertification examinations feel as though standard CMS is just as effective in skill maintenance as studying and sitting for a 200-question examination.
A new study demonstrates the efficacy of a structured physician compensation model in achieving equitable pay for all employees, although the underrepresentation of women in leadership positions and the higher-paying specialties warrants further investigation.
The United States routinely outspends other high-income countries on prescription drugs because of the lack of price controls or negotiation by government health care systems.
Medical school application costs may prevent students from lower-income backgrounds from entering the profession of medicine.
There is a prevalence of conflicts of interest and lack of transparency of reporting conflicts of interest in gastroenterology guideline authors.
The percentage of US physicians who believe that the ACA is a net positive for health care has increased in the five years after its implementation.
The Mayo Clinic has instituted a Patient and Visitor Conduct Policy that balances the dual needs of providing optimal patient care while maintaining a supportive, respectful workplace for staff.
